Exhibition Reflects Last 10 Years Of Chinese Bulk API Industry Development
This article was originally published in PharmAsia News
The scale of Shanghai's recently opened 10th World Exhibition on Pharmaceutical Ingredients (CPhI & ICSE China 2010) reflects the rapid developments in China's bulk drug industry over the last decade
You may also be interested in...
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.
As Chinese returnees transform their startups to fully-fledged biopharma operations with a full product lineup and the global market in sight, the journey has been filled with challenges. Based on interviews and on-the-ground reporting, this new series takes a closer look at several companies' experiences.
US FDA Will Need About A Week To Complete COVID Vaccine Assessment Following Advisory Cmte., CBER’s Marks Says
Timeline is the most pessimistic public projection to date, but still incredibly fast. Clinical trial patients on placebo could be contacted and offered the vaccine after an EUA is granted.